{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:49:52Z","timestamp":1792432192261,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ejmech.2019.03.036","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T10:55:49Z","timestamp":1552992949000},"page":"25-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents"],"prefix":"10.1016","volume":"171","author":[{"given":"Eman M.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa E.","family":"Kassab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf A.","family":"El-Malah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa S.A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.03.036_bib1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhito","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.03.036_bib2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF00920477","article-title":"Comparative evaluation of arachidonic acid (AA)-and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation","volume":"17","author":"Rao","year":"1993","journal-title":"Inflammation"},{"key":"10.1016\/j.ejmech.2019.03.036_bib3","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: how are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.ejmech.2019.03.036_bib4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jbt.20194","article-title":"Modulation of indomethacin-induced gastric injury by spermine and taurine in rats","volume":"21","author":"Motawi","year":"2007","journal-title":"J.\u00a0Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejmech.2019.03.036_bib5","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.91.8.3228","article-title":"Selective inhibition of inducible cyclooxygenase 2 in\u00a0vivo is antiinflammatory and nonulcerogenic","volume":"91","author":"Masferrer","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.03.036_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0223-5234(01)01197-7","article-title":"Cyclooxygenase inhibitors\u2013current status and future prospects","volume":"36","author":"Dannhardt","year":"2001","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.036_bib7","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1021\/jm960803q","article-title":"Synthesis and biological evaluation of the 1, 5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1 H-pyrazol-1-yl] benzenesulfonamide (SC-58635, celecoxib)","volume":"40","author":"Penning","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.036_bib8","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1016\/S0960-894X(98)00499-5","article-title":"2-Pyridinyl-3-(4-methylsulfonyl) phenylpyridines: selective and orally active cyclooxygenase-2 inhibitors","volume":"8","author":"Friesen","year":"1998","journal-title":"Bio. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.03.036_bib9","first-page":"26","article-title":"Choosing nonselective NSAIDs and selective COX-2 inhibitors in the elderly. A clinical use pathway","volume":"62","author":"Stillman","year":"2007","journal-title":"Geriatrics"},{"key":"10.1016\/j.ejmech.2019.03.036_bib10","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/01.ATV.0000219672.68024.bc","article-title":"COX-2 in cardiovascular disease, arterioscler","volume":"26","author":"Bishop-Bailey","year":"2006","journal-title":"Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejmech.2019.03.036_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nsb1196-927","article-title":"Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2","volume":"3","author":"Luong","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ejmech.2019.03.036_bib12","first-page":"26","article-title":"Cyclooxygenase-2 an attractive target for fruitful drug design","volume":"80","author":"Fabiola","year":"2001","journal-title":"Curr. Sci."},{"key":"10.1016\/j.ejmech.2019.03.036_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0223-5234(02)01336-3","article-title":"3-O-Substituted benzyl pyridazinone derivatives as COX inhibitors","volume":"37","author":"Chintakunta","year":"2002","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.036_bib14","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1016\/j.bmc.2008.04.007","article-title":"Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in\u00a0vivo activity","volume":"16","author":"Abouzid","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.036_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/BF02977751","article-title":"Synthesis, analgesic, and anti-inflammatory activities of [6-(3, 5-dimethyl-4- chloropyrazole-1-yl)-3(2H)-pyridazinon-2-yl] acetamides","volume":"28","author":"S\u00fck\u00fcroglu","year":"2005","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2019.03.036_bib16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ardp.200300778","article-title":"Investigations of new pyridazinone derivatives for the synthesis of potent analgesic and anti-inflammatory compounds with cyclooxygenase inhibitory activity","volume":"336","author":"\u00d6k\u00e7elik","year":"2003","journal-title":"Arch. Pharm. Pharm. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.036_bib17","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s12272-012-1205-5","article-title":"Synthesis and anti-inflammatory activity of novel pyridazine and pyridazinone derivatives as non-ulcerogenic agents","volume":"35","author":"Saeed","year":"2012","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2019.03.036_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/cber.19560890226","article-title":"The condensation of levulinic acid with aromatic aldehydes","volume":"89","author":"Zaheer","year":"1956","journal-title":"Chem. Ber."},{"key":"10.1016\/j.ejmech.2019.03.036_bib19","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.bmc.2013.03.017","article-title":"Analogs design, synthesis and biological evaluation of peptidomimetics with potential anti-HCV activity","volume":"21","author":"Lasheen","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.036_bib20","first-page":"200","article-title":"Synthesis, computer aided screening and pharmacological evalution of 2\/3-Substituted-6(4-Methylphenyl)-4,5-dihydropyridazin-3(2H)-ones, and pyridazine substituted triazine","volume":"26","author":"Khokra","year":"2015","journal-title":"Indones. J. Pharm."},{"key":"10.1016\/j.ejmech.2019.03.036_bib21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1055\/s-1995-4079","article-title":"Copper (II) chloride as an efficient reagent for the dehydrogenation of pyridazinone derivatives","author":"Csende","year":"1995","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2019.03.036_bib22","first-page":"614","volume":"39","author":"Khan","year":"2000"},{"key":"10.1016\/j.ejmech.2019.03.036_bib23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ejmech.2019.03.036_bib24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ejmech.2017.12.065","article-title":"Novel click modifiable thioquinazolinones as anti-inflammatory agents: design, synthesis, biological evaluation and docking study","volume":"144","author":"Moussa","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.036_bib25","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1016\/j.bmc.2011.06.019","article-title":"Analogue-based design, synthesis and molecular docking analysis of 2, 3-diaryl quinazolinones as non-ulcerogenic anti- inflammatory agents","volume":"1","author":"Manivannan","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.036_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(98)00688-8","article-title":"Effects of centrally or peripherally injected adrenomedullin on reserpine-induced gastric lesions","volume":"360","author":"Clementi","year":"1998","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419302545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419302545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:50:59Z","timestamp":1759326659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419302545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":26,"alternative-id":["S0223523419302545"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.03.036","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.03.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}